Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) was the target of a large decrease in short interest in February. As of February 13th, there was short interest totaling 9,025 shares, a decrease of 31.5% from the January 29th total of 13,176 shares. Based on an average daily volume of 49,744 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 49,744 shares, the days-to-cover ratio is presently 0.2 days.

Fresenius SE & Co. Price Performance

Shares of Fresenius SE & Co. stock traded down $0.11 on Friday, reaching $15.10. The company’s stock had a trading volume of 140,780 shares, compared to its average volume of 26,812. The company has a quick ratio of 0.99, a current ratio of 1.26 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $34.02 billion, a P/E ratio of 23.97 and a beta of 0.75. Fresenius SE & Co. has a 52-week low of $9.78 and a 52-week high of $33.93. The stock has a 50-day moving average price of $14.60 and a 200-day moving average price of $14.43.

Fresenius SE & Co. (OTCMKTS:FSNUY) last released its earnings results on Wednesday, February 25th. The company reported $0.28 earnings per share for the quarter. Fresenius SE & Co. had a return on equity of 10.38% and a net margin of 5.71%.The business had revenue of $6.94 billion for the quarter. Analysts expect that Fresenius SE & Co. will post 0.79 EPS for the current year.

Analysts Set New Price Targets

FSNUY has been the topic of a number of research analyst reports. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Citigroup reissued a “buy” rating on shares of Fresenius SE & Co. in a report on Tuesday, February 3rd. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.